Background: Mycobacterium avium complex (MAC)-lung disease (LD) is increasing in patients without human immunodeficiency virus infection. However, data on host vulnerability to MAC-related immune responses, and in particular the interleukin (IL)-23/IL-17 axis, are lacking.Shu, Chin-ChungWang, ...
BACKGROUND: MAC pulmonary disease is common in cancer patients. This study compares the clinical characteristics of the disease in solid organ vs. hematologic malignancies. METHODS: Retrospective review of medical records of all cancer patients with MAC isolated from respiratory specimens at the Universi...
MAC is the most common cause of infection by nontuberculous mycobacteria (NTM) in patients with AIDS. M avium is the isolate in more than 95% of patients with AIDS who develop MAC infections. MAC lung disease occurs rarely in immunocompetent hosts. Patients with underlying lung disease or ...
目前的国际治疗指南建议,对接受标准疗法治疗至少6个月失败的MAC肺病患者,推荐使用Arikayce与一种多药方案(MDR)联合应用。 原文出处:ARIKAYCE® (amikacin liposome inhalation suspension) approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by...
Purpose. The purpose of this paper was to review the imaging features of Mycobacterium avium-intracellulare complex (MAC) in 16 pediatric patients with hum... M Pursner,JO Haller,WE Berdon - 《Pediatric Radiology》 被引量: 39发表: 2000年 Mycobacterium Avium Complex (MAC) Lung Diseasein Two ...
Furthermore, higher MACC1 expression levels were associated with differentiation and blood vessel invasion in patients with small invasive lung adenocarcinoma, leading to a significant reduction in OS and disease-free survival [29]. In addition to the direct investigations performed in individual cancer...
原文出处:ARIKAYCE® (amikacin liposome inhalation suspension) approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR...
原文出处:ARIKAYCE® (amikacin liposome inhalation suspension)approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR...
54%, 26%, and 20% of patients were treated, untreated, or indeterminate, respectively. The percent of isolates susceptible to each agent between treated and untreated were similar for all agents. CONCLUSION. AMK and CLR remain highly active against MAC pulmonary isolates. Amongst isolates ...
(standardized patients, SP) 又称为模拟病人(Simulate Patients),指那些经过标准化、系统化培训后,能准确表现病人的实际临床问题的正常人或病人。与其他完整的测验方法不同,SP本身不是一种独立的考试方法,它通常是许多临床能力评估方法中的一部分。 ...